Pitavastatin Tablet, Film Coated
Product Images NDC 0480-3633

The text provides information about the treatment difference in adjusted mean percent change in LDL-C (low-density lipoprotein cholesterol) for various comparisons between different statin medications (Atorvastatin, Pitavastatin, Simvastatin, and Pravastatin). The text includes the sample size (n), treatment difference (THDiff), 95% confidence interval (95%C), and p-value for each comparison. It seems to be a study or clinical trial evaluating the effectiveness of different statin medications in reducing LDL-C levels.*

Dosage and use information for Pitavastatin tablets, each containing 1.045 mg of pitavastatin calcium (equivalent to 1 mg of pitavastatin), can be found in the package insert for the full prescribing information. The tablets should be stored at a temperature of 25°C (77°F), with excursions ranging from 15°C to 30°C (59°F to 86°F) permitted. It is important to protect the tablets from moisture and light, and they should be dispensed in a tightly sealed, light-resistant, and child-resistant container. The tablets come in a pack of 90 and are available only with a prescription. The product is manufactured by Orient Pharma Co, Ltd. in Yunlin, Taiwan and is distributed by Teva Pharmaceuticals in Parsippany, NJ, USA. The revision number is 001 and the expiration date is August 2022.*

Dosage and use: This text provides information about the dosage and use of a medication. It suggests referring to the Package Insert for Full Prescribing Information. Each film-coated tablet contains 2.0 g of pitavastatin calcium, which is equivalent to 2 mg of pitavastatin. The recommended storage temperature is 25°C (77°F), with excursions permitted between 15°C and 30°C (59°F to 86°F). The medication should be protected from moisture and light and dispensed in a tight, light-resistant, child-resistant container. The NDC number is 0480-3632-98. These are pitavastatin tablets and are only available with a prescription (Rxonly). This bottle contains 90 tablets and is manufactured by Orfent Pharma Co, Ltd. in Yunlin, Taiwan. The product is manufactured for Teva Pharmaceuticals in Parsippany, NJ, with a revision date of August 2022 (Rev.001, Rev.08/2022).*

This is a description for a medication called Pitavastatin. Each film-coated tablet contains 4.18 mg of pitavastatin calcium, which is equivalent to 4 mg of pitavastatin. The tablets should be stored at a temperature between 15°C to 30°C (59°F to 86°F) and should be protected from moisture and light. They should be dispensed in a tight, light-resistant, child-resistant container. The medication is manufactured by Orlent Pharma Co, Ltd. in Taiwan and is distributed by Teva Pharmaceuticals in Parsippany, NJ. The package contains 90 tablets. The full prescribing information can be found in the package insert.*